Issue 3/2022

The diagnostic contribution of magnetic resonance imaging in the detection of axillary metastasis after neoadjuvant chemotherapy

 Yakup İriağaç, Kubilay Karaboyun, Eyyüp Çavdar, Okan Avci, Tuğba Kurtoğlu Özçağlayan, Meltem Öznur, Sibel Ozkan Gurdal, Erdoğan Şeber

DOI: 10.4149/neo_2022_220127N122

Periostin: a predictable molecule to prognosis and chemotherapy responses of gastrointestinal and hepato-biliary-pancreatic malignant tumors? (491 — 503)

Wei Zhang, Fa-Hong Wu, Jia Wang, Hang-Zhi Wei, Tian-Wei Wang,  You-Cheng Zhang

DOI: 10.4149/neo_2021_211025N1521

Drug therapy for bone metastasis of malignant tumor: theory, progress, and potential (504 — 515)

Ji-Zheng Tian, Ni-Na Ma, Xiao Li, Kun Shang,  Bang-Wei Cao

DOI: 10.4149/neo_2021_211006N1412

Exosomal circRNAs as novel potential biomarkers for colorectal adenoma (516 — 526)

Shaobing Cheng, Sen Lu,  Fanlong Liu

DOI: 10.4149/neo_2021_210718N986

Identification of circRNAs involved in the development of hepatocellular carcinoma after insufficient radiofrequency ablation (527 — 537)

Jun-Wei Chen, Li-Sha Lai, Jun-Yang Luo, Chu-Ren Zhou, Min-Gan Li,  Ming-Sheng Huang,  Ping Wu

DOI: 10.4149/neo_2021_210817N1170

Tumor suppressive lncRNA MEG3 binds to EZH2 and enhances CXCL3 methylation in gallbladder cancer (538 — 549)

De-Qiang Li, Yi-Ren Ding, Jin-Hui Che, Zhan Su, Wei-Zhong Yang, Lu Xu, Yun-Jiu Li,  Hai-Hong Wang,  Wu-Yuan Zhou

DOI: 10.4149/neo_2022_210726N1046

Elevation of miR-125b-5p is related to improved prognosis in laryngeal squamous cell carcinoma and inhibits the malignancy and glycometabolic disorder by targeting MAP3K9 (550 — 559)

 Fu Chen, Zheng Lao, Hai-Yan Zhang, Jie Wang,  Sheng-Zi Wang

DOI: 10.4149/neo_2022_211027N1532

sh-HNF1A-AS1 reduces the epithelial-mesenchymal transition and stemness of esophageal cancer cells (560 — 570)

Zheng Wang,  Yan-Feng Huang, Ling Yu, Yue Jiao

DOI: 10.4149/neo_2022_211102N1555

Skimmianine as a novel therapeutic agent suppresses proliferation and migration of human esophageal squamous cell carcinoma via blocking the activation of ERK1/2 (571 — 582)

Yang Liu, Lin Kang, Shao-Min Shi, Bing-Jie Li, Yang Zhang, Xiu-Zhi Zhang, Xiao-Wan Guo, Gang Fu, Guo-Na Zheng,  Han Hao,  Huan-Fen Zhao

DOI: 10.4149/neo_2022_211118N1640

LncRNA BCYRN1 promotes cell migration and invasion of non-small cell lung cancer via the miR-30b-3p/ROCK1 axis (583 — 593)

Shu Song, Wei-Gang Bian, Zhu Qin, Dong Zeng, Jing-Jing Xu,  Hai-Cheng Tang

DOI: 10.4149/neo_2022_210726N1045

LncRNA NEAT1-associated aerobic glycolysis blunts tumor immunosurveillance by T cells in prostate cancer (594 — 602)

Kai-Guo Xia, Chang-Ming Wang, De-Yun Shen, Xiao-Yuan Song, Xiang-Yu Mu, Jia-Wei Zhou, An-Yang Zhu,  Qiang Xuan,  Tao Tao

DOI: 10.4149/neo_2022_211021N1497

Dictamnine inhibits pancreatic cancer cell growth and epithelial-mesenchymal transition by blocking the PI3K/AKT signaling pathway (603 — 619)

Zhi-Qiang Zhang, Wen-Liang Xuan, Yang Huang, Shuo Ren, Tu-Ya Wulan, Ye Song, Dong-Bo Xue,  Wei-Hui Zhang

DOI: 10.4149/neo_2022_211016N1474

Iodine-125 induced cholangiocarcinoma cell death is enhanced by inhibition of endoplasmic reticulum stress-mediated protective autophagy (620 — 629)

Lei Zou, Wei Chang, Jian-Hua Bai, Wan-Hong Shi, Yun Jin, Jun-Feng Wang,  Kun-Hua Wang

DOI: 10.4149/neo_2022_211102N1556

Glucose and glutamine metabolism-related protein expression in breast ductal carcinoma in situ (630 — 639)

Hyang Ryu,  Ja Koo

DOI: 10.4149/neo_2022_220103N3

ARHGAP17 enhances 5-Fluorouracil-induced apoptosis in colon cancer cells by suppressing Rac1 (640 — 647)

 Sheng-Li Pan, Ying-Ying Deng, Jun Fu, Yu-Hao Zhang, Zhi-Jin Zhang,  Xian-Ju Qin

DOI: 10.4149/neo_2022_211006N1410

Co-treatment of betulin and gefitinib is effective against EGFR wild-type/KRAS-mutant non-small cell lung cancer by inducing ferroptosis (648 — 656)

Wei-Ya Yan, Jian Cai, Jiang-Nan Wang,  Yong-Sheng Gong,  Xue-Bing Ding

DOI: 10.4149/neo_2022_211103N1568

CDC Like Kinase 2 plays an oncogenic role in colorectal cancer via modulating the Wnt/β-catenin signaling (657 — 669)

Hai-Bo Zhou, Li Yang, Shi-Fang Liu, Xin-Hua Xu, Zhuo Chen, Yun-Xiao Li,  Jin-Hua Yuan,  Yong-Chang Wei

DOI: 10.4149/neo_2022_220206N138

CX3CL1 in the red bone marrow promotes renal cell carcinoma to metastasize to the spine by involving the Src-related pathway (670 — 679)

An-Nan Hu, Fan-Cheng Chen, Ke-Tao Wang, Zhen-Qing Wang, Yun Liang,  Jian Dong

DOI: 10.4149/neo_2022_211205N1728

Epigenetic network of EZH2/SFRP1/Wnt in the epithelial-mesenchymal transition of laryngeal carcinoma cells (680 — 690)

Wei Chen, Hua-Tao Wang, Jun-Feng Ji, Zhi-Yi Wang, Tao Shi, Ming-Hai Wu,  Peng-Ju Yu

DOI: 10.4149/neo_2022_211208N1749

The predictive value and correlation of β-catenin, CMTM6, and PD-L1 expression in colorectal cancer (691 — 699)

Bingquan Li, Shigang Wu, Zhanlong Qiu, Xuejun Zhong, Zhe Chen, Feng Luo, Jinbang Li,  Kunping Liu

DOI: 10.4149/neo_2022_210809N1122

Does the primary tumor site in stage I extranodal natural killer/T-cell lymphoma matter? (700 — 707)

Juan-Juan Cui, Jing Cai, Qi-Wei Zhu, Yuan-Qi Bei, Bai-Xia Yang,  Xue-Jun Ma

DOI: 10.4149/neo_2022_211004N1407

Development of a model for predicting risk from breast interval cancer in the female population in the Republic of Croatia (708 — 722)

 Romana Tandara Haček, Nataša Antoljak, Marijan Erceg

DOI: 10.4149/neo_2022_211118N1642

Does postpneumonectomy empyema improve long-term survival for patients with lung cancer? (723 — 728)

Janusz Wójcik, Krzysztof Safranow, Jarosław Pieróg,  Norbert Wójcik, Małgorzata Wojtyś, Tomasz Grodzki

DOI: 10.4149/neo_2022_211207N1746

New insights into the diagnostic characteristics and clinical application of serum biomarkers for lung cancer, and human epididymis protein 4 as a new biomarker? (729 — 740)

Ming Li, Yi Zhang, Li Jiang, Yan Li, Gang Li, Jianping Zhou, Chen Yang, Xinhui Li, Wei Qu, Yong Chen, Qing Chen, Shukui Wang, Jinliang Xing,  Huayi Huang

DOI: 10.4149/neo_2022_220207N144